Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study of Abemaciclib With Bevacizumab in Recurrent Glioblastoma Patients With Loss of CDKN2A/B or Gain or Amplification of CDK4/6

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04074785
Recruitment Status : Recruiting
First Posted : August 30, 2019
Last Update Posted : December 16, 2020
Sponsor:
Information provided by (Responsible Party):
Edward Pan, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 24, 2021
Estimated Study Completion Date : October 24, 2022